Serum amyloid P-component is an acute-phase reactant in the mouse

Nature ◽  
1979 ◽  
Vol 278 (5701) ◽  
pp. 259-261 ◽  
Author(s):  
M. B. PEPYS ◽  
MARILYN BALTZ ◽  
K. GOMER ◽  
A. J. S. DAVIES ◽  
M. DOENHOFF
Amyloidosis ◽  
1986 ◽  
pp. 87-97 ◽  
Author(s):  
Shunsuke Migita ◽  
Shigeru Hashimototo ◽  
Haruo Hisazumi ◽  
Mine Harada ◽  
Hiroaki Okabe

Inflammation ◽  
1990 ◽  
Vol 14 (3) ◽  
pp. 297-313 ◽  
Author(s):  
Bih-Fen Lin ◽  
Nam-On Ku ◽  
Kamyar Zahedi ◽  
Alexander S. Whitehead ◽  
Richard F. Mortensen

1986 ◽  
Vol 55 (03) ◽  
pp. 406-409 ◽  
Author(s):  
B A Fiedel ◽  
Cecilia S L Ku

SummarySerum amyloid P component (SAP), and its acute phase homologue C-reactive protein (CRP), prolonged activated partial thromboplastin times (APTT) in cell free plasma when assayed at physiological concentrations in the presence of heparin. SAP also inhibited clot formation initiated through the extrinsic and terminal phases of coagulation in heparinized cell free plasma, an activity not shared with CRP. When CRP and SAP were similarly evaluated in whole blood using the thromboelastograph (TEG), CRP delayed the onset of coagulation and the initial rate of fibrin formation/polymerization; final clot patency was unaltered. SAP suppressed the anticoagulant activity of heparin in the TEG assay, unlike results obtained in heparinized cell free plasma, by facilitating a more rapid onset of coagulation, increasing the rate of fibrin formation/polymerization, and correcting clot patency. The data provided offer further evidence that these homologues can intercede in blood coagulation.


Sign in / Sign up

Export Citation Format

Share Document